INJ Search

CLOSE


Int Neurourol J > Volume 27(4); 2023 > Article
Cho: From Code to Cure: Unleashing the Power of Generative Artificial Intelligence in Medicine
In the rapidly evolving landscape of healthcare, a groundbreaking force has emerged, poised to transform the way we approach medical challenges. Generative artificial intelligence (AI) has stepped into the limelight, demonstrating its potential to revolutionize medicine, with 2023 marking a pivotal year in its application. As we navigate through the intricate intersection of technology and healthcare, one cannot overlook the profound impact generative AI has made, particularly in the field of urology.
Urology, traditionally a domain requiring meticulous expertise, has found a new ally in generative AI. This innovative technology surpassed conventional diagnostic methods, presenting a dynamic approach to patient care and treatment. The marriage of machine learning algorithms and medical data has enabled generative AI to sift through vast datasets, identifying patterns and correlations that may elude the human eye [1,2].
Furthermore, the application of generative AI extends to treatment strategies in urology. Tailoring treatment plans to individual patient profiles is a complex task that requires a nuanced understanding of the interplay between various factors [3]. Generative AI excels in this arena by synthesizing diverse patient data to recommend personalized treatment options. This not only optimizes therapeutic efficacy but also minimizes the risk of adverse effects, ushering in a new era of precision medicine [4,5].
However, as we celebrate the strides made by generative AI in urology, it is crucial to address challenges and ethical considerations. Ensuring the responsible and ethical use of AI in healthcare is paramount, emphasizing transparency, patient consent, and continuoud scrutiny of algorithmic decisions [6,7].
In conclusion, the symbiosis of generative AI and urology heralds a new dawn in medical innovation. “From Code to Cure” encapsulates the essence of this transformative journey, where lines of code become beacons of hope for those navigating the complexities of urological conditions. As we stand at the crossroads of technology and healing, the potential of generative AI in medicine beckons us to explore, innovate, and above all, prioritize the well-being of those we aim to heal [8].
I am delighted to share that the International Neurourology Journal remains committed to its mission of advancing knowledge in the field of neurourology. As we bid farewell to 2023, we pledge to persist in our efforts to provide valuable insights and research findings to our readers. The coming year holds the promise of further collaboration, learning, and growth, and we are dedicated to working tirelessly for the sake of our readers and the continued development of neurourology.
As we approach the close of the transformative year that has been 2023, I extend warm greetings to each of you within the esteemed community of medical professionals and researchers. It has been a year marked by groundbreaking advancements, steadfast dedication, and unwavering commitment to the pursuit of knowledge and healing.
Wishing you a joyous holiday season and a prosperous New Year.

NOTES

Conflict of Interest
No potential conflict of interest relevant to this article was reported.

REFERENCES

1. Nedbal C, Naik N, Castellani D, Gahuar V, Geraghty R, Somani BK. ChatGPT in urology practice: revolutionizing efficiency and patient care with generative artificial intelligence. Curr Opin Urol 2023 Nov 14;doi: 10.1097/MOU.0000000000001151. [Epub]. PMID: 37962176
crossref pmid
2. Szczesniewski JJ, Tellez Fouz C, Ramos Alba A, Diaz Goizueta FJ, García Tello A, Llanes González L. ChatGPT and most frequent urological diseases: analysing the quality of information and potential risks for patients. World J Urol 2023;41:3149-53. PMID: 37632558
crossref pmid pdf
3. Choi HS, Kim JS, Whangbo TK, Eun SJ. Improved detection of urolithiasis using high-resolution computed tomography images by a vision transformer model. Int Neurourol J 2023;27(Suppl 2):S99-103. PMID: 38048824
crossref pmid pmc pdf
4. Cho Y, Park JM, Youn S. General overview of artificial intelligence for interstitial cystitis in urology. Int Neurourol J 2023;27(Suppl 2):S64-72. PMID: 38048820
crossref pmid pmc pdf
5. Na J, Kim SJ, Lim Y. Designing digital therapeutic content using chronic disease data: a focus on improving urinary dysfunction. Int Neurourol J 2023;27(Suppl 2):S51-63. crossref pdf
6. Javid M, Reddiboina M, Bhandari M. Emergence of artificial generative intelligence and its potential impact on urology. Can J Urol 2023;30:11588-98. PMID: 37633285
pmid
7. Kim KH. Transformation in neurourology. Int Neurourol J 2023;27(Suppl 2):S49-50. PMID: 38048818
crossref pmid pmc pdf
8. Kim ES, Eun SJ, Kim KH. Artificial intelligence-based patient monitoring system for medical support. Int Neurourol J 2023;27:280-6. crossref
TOOLS
Share :
Facebook Twitter Linked In Google+
METRICS Graph View
  • 0 Crossref
  • 0 Scopus
  • 652 View
  • 29 Download
We recommend


ARTICLE & ORGAN
Article Category

Browse all articles >

Organ

Browse all articles >

ISSUES
DISEASES & TOPICS
Diseases

Browse all articles >

Topics

Browse all articles >

AUTHOR
INFORMATION

Official Journal of Korean Continence Society & ESSIC (International Society for the Study of BPS) & Korean Society of Urological Research & The Korean Children’s Continence and Enuresis Society & The Korean Association of Urogenital Tract Infection and Inflammation & Korean Society of Geriatric Urological Care
Editorial Office
Department of Urology, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine,
29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea
Tel: +82-2-2001-2237     Fax: +82-2-2001-2247    E-mail: choys1011@naver.com

Copyright © 2024 by Korean Continence Society.

Developed in M2PI

Close layer
prev next